125 related articles for article (PubMed ID: 37962565)
1. Recurrence Patterns and Clinical Management after a Positive Sentinel Node Biopsy in Melanoma Patients.
de Menezes JN; Arra DASM; Lôbo MM; Pinto CAL; Lima JPSN; Silva MJB; Duprat Neto JP; Bertolli E
Cancer Invest; 2023 Dec; 41(10):830-836. PubMed ID: 37962565
[TBL] [Abstract][Full Text] [Related]
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
3. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy.
Ipenburg NA; Nieweg OE; Uren RF; Thompson JF
Ann Surg Oncol; 2017 Jan; 24(1):117-126. PubMed ID: 27480356
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
6. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
7. Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients.
Ipenburg NA; Thompson JF; Uren RF; Chung D; Nieweg OE
Ann Surg Oncol; 2019 Sep; 26(9):2855-2863. PubMed ID: 31240588
[TBL] [Abstract][Full Text] [Related]
8. Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients.
Fonseca IB; Lindote MVN; Monteiro MR; Doria Filho E; Pinto CAL; Jafelicci AS; de Melo Lôbo M; Calsavara VF; Bertolli E; Duprat Neto JP
Ann Surg Oncol; 2020 Oct; 27(11):4133-4140. PubMed ID: 32767223
[TBL] [Abstract][Full Text] [Related]
9. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
[TBL] [Abstract][Full Text] [Related]
10. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
[TBL] [Abstract][Full Text] [Related]
11. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
14. In transit sentinel node drainage as a prognostic factor for patients with cutaneous melanoma.
Brandão PHDM; Bertolli E; Doria-Filho E; Santos Filho IDAO; de Macedo MP; Pinto CAL; Duprat Neto JP
J Surg Oncol; 2018 Apr; 117(5):864-867. PubMed ID: 29484669
[TBL] [Abstract][Full Text] [Related]
15. The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma.
Ross GL; Shoaib T; Scott J; Camilleri IG; Gray HW; MacKie R; Soutar DS
Br J Plast Surg; 2003 Mar; 56(2):153-5. PubMed ID: 12791361
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
17. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
19. Challenges in sentinel node pathology in the era of adjuvant treatment.
Franke V; Madu MF; Bierman C; Klop WMC; van Houdt WJ; Wouters MWJM; van de Wiel BA; van Akkooi ACJ
J Surg Oncol; 2020 Oct; 122(5):964-972. PubMed ID: 32602119
[TBL] [Abstract][Full Text] [Related]
20. Locoregional Lymph Node Recurrence of Trunk Melanoma in Non-sentinel Lymph Node Basins: An Observational Retrospective Study.
Moro R; González-Ramos J; Martínez-García S; Requena C; Traves V; Manrique-Silva E; Nagore E
Acta Derm Venereol; 2020 Oct; 100(17):adv00284. PubMed ID: 32945339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
